Although the mechanisms continue to be studied, a therapeutic strategy that modifies both muscle and non-muscle symptoms and applies across DMD and LGMD-2C-F, the two most common and debilitating groups of muscular dystrophies, is highly significant clinically.
← all excerpts
The Role of P2X7 Purinoceptors in the Pathogenesis and Treatment of Muscular Dystrophies.
1
—
—